Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Susan E. Dorman(Medical University of South Carolina), Richard E. Chaisson(Johns Hopkins University), Kelly E. Dooley(Johns Hopkins University), Payam Nahid(University of California, San Francisco), Ziyaad Waja(The University of Texas at San Antonio Health Science Center), Grace Muzanyi(The University of Texas at San Antonio Health Science Center), Marc Weiner(The University of Texas at San Antonio Health Science Center), Stefan Goldberg, Patrick Phillips(Unknown), Nigel Scott(Royal Preston Hospital), Madeleine Lourens(The University of Texas at San Antonio Health Science Center), Justin Shenje(The University of Texas at San Antonio Health Science Center), Wadzanai Samaneka(University of Zimbabwe), Susan Swindells(University of Nebraska Medical Center), Anne Purfield(The University of Texas at San Antonio Health Science Center), Radojka M. Savić(University of California, San Francisco), Ha Phan(The University of Texas at San Antonio Health Science Center), Sandy Nerette(The University of Texas at San Antonio Health Science Center), Erin Sizemore(The University of Texas at San Antonio Health Science Center), Andrew Vernon(The University of Texas at El Paso), Kia Bryant(The University of Texas at San Antonio Health Science Center), Samuel Pierre(Polytechnique Montréal), Melissa Engle(The University of Texas at San Antonio Health Science Center), Neil Martinson(University of the Witwatersrand), Nguyen Viet Nhung(VNU University of Science), Ekaterina V. Kurbatova(The University of Texas at San Antonio Health Science Center), James Hakim(University of Zimbabwe), Ian Sanne(The University of Texas at San Antonio Health Science Center), Thuong Pham(The University of Texas at San Antonio Health Science Center), John L. Johnson(University School), Kim Narunsky(University of Cape Town)
Cited by 548
Related Papers
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k